SBIR/STTR Research Award

Finding Human Carriers of Taeniasis to Prevent Neurocysticercois Associated Epilepsy

Award identifier cfcbc791529eff683f8c8347bc4b99ea719244011a6a0f124a2bfd5c37e3553eAwarding agency Department of Health and Human Services · Centers for Disease Control and Prevention

Award amount

$126,680

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Centers for Disease Control and Prevention
Recipient company
APTAGEN LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
HEK9BF17MKL3
Solicitation number
Not reported
Topic code
ODCDC

Research abstract

NeurocycsticercosisNCCis a leading cause of adult onset epilepsy in the developing world and an increasing public health concern in the United StatesNCC develops in individuals infected with tape worm Taenia soliumTsoliumHowevermost people are unaware of their infection before neurological symptoms appearthus posing a major risk of transmitting the infectionReliable diagnosis and efficacious treatment of taeniasis are needed for disease controlCurrently available laboratory tools to screen for Tsolium carriers have been inefficientIn this SBIRwe propose to identify five high affinity aptamers targeting Tsolium adult worm extracts in positive stool samples using a Capture Systematic Evolution of Ligands by EXponential EnrichmentCapture SELEXstrategyAt Aptagenwe have developed proprietary protocols to improve the specificity of Capture SELEX process to identify high affinity aptamers against intended targetsOur research team has extensive experience and expertise in aptamer selection technologies to ensure successful execution and completion of the proposed project goalsSuccessful development of target specific aptamers that differentiate Tsolium positive stool samples from negative samples should lead to the development of a highly sensitive enzyme linked oligonucleotide assayELONAand a reliable quantitative point of care dipsticklateral flowtest for screening of at risk groups

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2018–2019). Reported award amounts total $1,115,980. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.